InvestorsHub Logo
Followers 1
Posts 94
Boards Moderated 0
Alias Born 09/03/2019

Re: None

Thursday, 04/02/2020 3:25:12 PM

Thursday, April 02, 2020 3:25:12 PM

Post# of 44784
Fda (relating to good news soon)
May be.
But
My assumption is that psti wouldn’t easily expand the no. of patients treated
Without outside promoters. especially when there is home u.s company nominated.
(Except if they have definite results from the 3 in israel which is a very
Dangerous trial for the company since they where in dying situation)
therefore any assertive demand will help giving pluristem wide variety
Of patient’s situation to proof their s cells. (The note of Paul Knoepfler
contrary to vast amount of cell experts that support Msc sequence,
didn’t stop Cellularity from being appointed to do the trial.)
So Everyone here should help by writing/calling to the relevant
Factors with forceful demand to add all relevant companies to the trial.